Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Inspire IVF PCLBKK:IVF +2.70%18 EBITDA Margin % is -42.88% as of Mar. 2026. GuruFocus rates BKK:IVF with a GF Score™ of 18/100. The stock has 3 warning signs investors should review. Among 664 Healthcare Providers & Services companies, Inspire IVF PCL ranks worse than 84.04% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Inspire IVF PCL's EBITDA for the
three
months ended in Mar. 2026 was ฿-5.84 Mil. Inspire IVF PCL's Revenue for the
three
months ended in Mar. 2026 was ฿13.62 Mil. Therefore, Inspire IVF PCL's EBITDA margin for the quarter that ended in Mar. 2026 was -42.88%.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Inspire IVF PCL EBITDA Margin % Related Terms
Inspire IVF PCL EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Inspire IVF PCL's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BKK:IVF vs HCA, THC, DVA: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, Inspire IVF PCL's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Inspire IVF PCL EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Inspire IVF PCL's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Inspire IVF PCL's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Inspire IVF PCL (BKK:IVF) has a EBITDA Margin % of -42.88% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Inspire IVF PCL and its competitors. According to the industry distribution chart, Inspire IVF PCL ranks #558 out of 664 companies in the Healthcare Providers & Services industry, placing it in the top 84%.
Is Inspire IVF PCL's EBITDA Margin % too high?
Inspire IVF PCL's current EBITDA Margin % is -42.88%. Based on the distribution chart, Inspire IVF PCL ranks #558 out of 664 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Inspire IVF PCL has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Inspire IVF PCL's EBITDA Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Inspire IVF PCL ranks #558 out of 664 companies for EBITDA Margin %. This places Inspire IVF PCL in the lower half of its industry. The industry median EBITDA Margin % is 10.24. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.24, based on 664 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Inspire IVF PCL and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Inspire IVF PCL's current EBITDA Margin % is -42.88%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Inspire IVF PCL stock overvalued right now?
Inspire IVF PCL (BKK:IVF) has a current EBITDA Margin % of -42.88%. The current EBITDA Margin % is -42.88%. Inspire IVF PCL's overall GF Score™ is 18/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Inspire IVF PCL (BKK:IVF), the current EBITDA Margin % is -42.88% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Inspire IVF PCL operates a comprehensive fertility treatment center, offering services ranging from consultations to selecting the appropriate treatment for each couple. It is principally engaged in infertility treatment and counseling services treatment with anti-aging medicine and health restoration, hemodialysis, blood filtration, and plasma filtration. The company operates in a single geographic area, Thailand.
18GF Score
Get the complete analysis for BKK:IVF
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:IVF has been successfully added to your 
